Results 141 to 150 of about 2,882,240 (203)

Mutations in the HIV-1 3'-Polypurine Tract and Integrase Strand Transfer Inhibitor Resistance. [PDF]

Antimicrob Agents Chemother, 2021
Wei Y, Sluis-Cremer N.
europepmc   +1 more source

Association between integrase strand transfer inhibitor use with insulin resistance and incident diabetes mellitus in persons living with HIV: a systematic review and meta-analysis. [PDF]

BMJ Open Diabetes Res Care, 2023
Mulindwa F, Kamal H, Castelnuovo B, Byonanebye DM, Schwarz JM, Bollinger R, Brusselaers N.   +6 more
europepmc   +1 more source

Perinatal and early infant outcomes after first-versus second-generation integrase strand transfer inhibitor use in pregnancy. [PDF]

HIV Med
Balleny R, Wong JMH, Lee T, Bitnun A, Boucoiran I, Brophy J, Comeau J, Kakkar F, McConnell A, Sauvé L, Singer J, Tse-Chang A, Money D.   +12 more
europepmc   +1 more source

Integrase Strand Transfer Inhibitor Start or Switch Impacts Learning in Women With HIV. [PDF]

J Acquir Immune Defic Syndr, 2021
O'Halloran JA, Wang K, Spence AB, Williams DW, Dastgheyb R, Fitzgerald KC, Kamkwalala AR, Maki PM, Sharma A, Gustafson DR, Milam J, Weber KM, Adimora AA, Ofotokun I, Fischl MA, Konkle-Parker D, Lahiri CD, Sheth AN, Xu Y, Rubin LH.   +19 more
europepmc   +1 more source

Time to Antiretroviral Therapy Initiation After HIV Diagnosis in the Integrase Strand Transfer Inhibitor Era - Nanjing City, Jiangsu Province, China, 2021-2024. [PDF]

China CDC Wkly
Ma C, Yang J, Liu A, Qian Z, Liu Z, Ge Y, Xu Y, Zhu Z, Wei H, Peng Z, Yin G, Hu Z.   +11 more
europepmc   +1 more source

Gut Bacterial Communities in HIV-Infected Individuals with Metabolic Syndrome: Effects of the Therapy with Integrase Strand Transfer Inhibitor-Based and Protease Inhibitor-Based Regimens. [PDF]

Microorganisms, 2023
Baltazar-Díaz TA, Amador-Lara F, Andrade-Villanueva JF, González-Hernández LA, Cabrera-Silva RI, Sánchez-Reyes K, Álvarez-Zavala M, Valenzuela-Ramírez A, Del Toro-Arreola S, Bueno-Topete MR.   +9 more
europepmc   +1 more source

Effectiveness and safety of integrase strand transfer inhibitors in Spain

Second-generation integrase strand transfer inhibitors (INSTIs) are preferred treatment options worldwide, and dolutegravir (DTG) is the treatment of choice in resource-limited settings. Nevertheless, in some resource-limited settings, these drugs are not always available. An analysis of the experience with the use of INSTIs in unselected adults living
Santos, José Ramón||, Casadellà, Maria||, Noguera-Julian, Marc||, Micán-Rivera, R., Domingo, Pere||, Antela, A., Portilla, J., Sanz Sanz, Jesús, Montero-Alonso, M., Navarro, Jordi||, Masiá, M., Valcarce-Pardeiro, Nieves, Ocampo, A., Pérez-Martínez, L., García-Vallecillos, C., Vivancos-Gallego, María J||, Imaz, Arkaitz||, Iribarren, José Antonio, Hernández-Quero, J., Villar Garcia, Judit||, Barrufet, M. Pilar||, Paredes, Roger||   +21 more
openaire   +1 more source

Fluorescent HIV-1 integrases for a suite of new user-friendly stability, nucleic acid binding and strand transfer activity assays

Human immunodeficiency virus (HIV) infects CD4+ T-cells, causing acquired immunodeficiency syndrome. Despite advances in antiretroviral therapy, drug resistance remains a critical issue. HIV integrase is a key therapeutic target.
Sorenson, Alanna E., Schaeffer, Patrick M., Bourquin, Rebecca A.   +2 more
core   +1 more source

Dual Long-Acting Cabotegravir/Rilpivirine Plus Lenacapavir in Integrase Strand Transfer Inhibitor Resistance: A Case Report and Review of the Literature. [PDF]

Open Forum Infect Dis
Seo L, Reilly-Evans B, Garland J.
europepmc   +1 more source

Weight Gain and Lipid Profile Changes in Koreans with Human Immunodeficiency Virus undergoing Integrase Strand Transfer Inhibitor-Based Regimens. [PDF]

Infect Chemother, 2022
Kim J, Nam HJ, Jung YJ, Lee HJ, Kim SE, Kang SJ, Park KH, Chang HH, Kim SW, Chung EK, Kim UJ, Jung SI.   +11 more
europepmc   +1 more source